Could HBx Protein Expression Affect Signal Pathway Inhibition by Gefitinib or Selumetinib, a MEK Inhibitor, in Hepatocellular Carcinoma Cell Lines?

Hepatitis B virus X (HBx) protein has been known to play an important role in development of hepatocellular carcinoma (HCC). The aim of this study is to find out whether HBx protein expression affects antiproliferative effect of an epidermal growth factor receptor-tyrosine kinase (EGFR-TK) inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yoon Kyung, Kim, Kang Mo, Lee, Young-Joo, Kim, Ki-Hun, Lee, Sung-Gyu, Lee, Danbi, Shim, Ju Hyun, Lim, Young-Suk, Lee, Han Chu, Chung, Young-Hwa, Lee, Yung Sang, Suh, Dong Jin
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031005/
https://www.ncbi.nlm.nih.gov/pubmed/21286012
http://dx.doi.org/10.3346/jkms.2011.26.2.214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031005/
https://www.ncbi.nlm.nih.gov/pubmed/21286012
http://dx.doi.org/10.3346/jkms.2011.26.2.214

Ejemplares similares